@article{280a71751658483b84c934472e01fd9d,
title = "Radioimmunotherapy with 90Y-DOTA-BC8 (anti-CD45 Antibody): Effect of Spleen Size and Uptake on Bone Marrow Absorbed Dose",
author = "Manuela Matesan and Darrell Fisher and Roger Wong and Damian Green and Johnnie Orozco and John Pagel and Ajay Gopal and Brenda Sandmaier and Oliver Press and Joseph Rajendran",
note = "1Dade Moeller Health Group Richland WA United States 2Fred Hutchkinson Cancer Research Center Seattle WA United States 3University of Washington Medical Center Seattle WA United States 1018 Objectives 90Y-DOTA-BC8 (anti-CD45 antibody) is being investigated as a treatment for hematologic malignancies in several ongoing clinical trials at the Fred Hutchinson Cancer Research Center.",
year = "2016",
month = may,
day = "1",
language = "American English",
volume = "57",
journal = "The Journal of Nuclear Medicine",
}